CIK 0000818033 · Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 942875566
- Phone
- 8582514400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-13 | POYHONEN JOHN President & CCO | Option exercise | +1,250 | 36,492 | ||
| 2022-10-13 | POYHONEN JOHN President & CCO | Option exercise | +4,564 | 41,056 | ||
| 2022-10-13 | POYHONEN JOHN President & CCO | Shares withheld for taxes | −2,012 | $3.76 | $8K | 39,044 |
| 2022-10-13 | POYHONEN JOHN President & CCO | Option exercise · Restricted Stock Units | −1,250 | 10,000 | ||
| 2022-10-13 | POYHONEN JOHN President & CCO | Option exercise · Restricted Stock Units | −4,564 | 37,064 | ||
| 2022-10-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise | +553 | 19,518 | ||
| 2022-10-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise | +1,932 | 21,450 | ||
| 2022-10-13 | Peraza Lisa VP, Chief Accounting Officer | Shares withheld for taxes | −861 | $3.76 | $3K | 20,589 |
| 2022-10-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise · Restricted Stock Units | −553 | 4,416 | ||
| 2022-10-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise · Restricted Stock Units | −1,932 | 15,694 | ||
| 2022-10-13 | MANHARD KIMBERLY EVP, Drug Development | Option exercise | +1,250 | 15,924 | ||
| 2022-10-13 | MANHARD KIMBERLY EVP, Drug Development | Option exercise | +4,564 | 20,488 | ||
| 2022-10-13 | MANHARD KIMBERLY EVP, Drug Development | Shares withheld for taxes | −2,012 | $3.76 | $8K | 18,476 |
| 2022-10-13 | MANHARD KIMBERLY EVP, Drug Development | Option exercise · Restricted Stock Units | −1,250 | 10,000 | ||
| 2022-10-13 | MANHARD KIMBERLY EVP, Drug Development | Option exercise · Restricted Stock Units | −4,564 | 37,064 | ||
| 2022-07-25 | Szekeres David Leslie EVP, Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +165,961 | 165,961 | ||
| 2022-07-25 | POYHONEN JOHN President & CCO | Grant or award · Employee Stock Option (Right to Buy) | +165,961 | 165,961 | ||
| 2022-07-25 | Peraza Lisa VP, Chief Accounting Officer | Grant or award · Employee Stock Option (Right to Buy) | +60,902 | 60,902 | ||
| 2022-07-25 | MANHARD KIMBERLY EVP, Drug Development | Grant or award · Employee Stock Option (Right to Buy) | +165,961 | 165,961 | ||
| 2022-07-13 | Szekeres David Leslie EVP, Chief Operating Officer | Option exercise | +1,250 | 14,340 |
Page 19 of 28 · 557 trades